Select region

Subscribe to our news feed

Subscribe

A question?

18.07.2025
Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions

“The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 4.1% while order intake rose by 4.4% organically.

10.07.2025
Getinge and Zimmer Biomet announce strategic partnership in the ASC sector

GOTHENBURG, SWEDEN AND WARSAW, IND. – July 10, 2025 – Global MedTech companies Getinge and Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), today announced a strategic partnership where Zimmer Biomet will distribute Getinge’s Operating Room (OR) capital products to its Ambulatory Surgery Center (ASC) customers. This partnership creates a turnkey solution for ASC customers, who can now access Getinge’s infection control and surgical portfolio and Zimmer Biomet’s broad menu of best-in-class implants and surgical robotics from a single source.

04.07.2025
Getinge invites fund managers, analysts, and media to Q2 Report 2025 conference call

Getinge will issue its Q2 Report 2025 on July 18, 2025, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

30.06.2025
Getinge extends the Servo-c ventilator with a neonatal option

Getinge announces the extension of its Servo-c ventilator with a neonatal option, transforming it into a universal solution that supports respiratory care for all patient categories – from fragile premature newborns to fully grown adults.

27.06.2025
Fluorescence imaging – a game-changer for endocrine surgery in German university hospital

Using Getinge’s Fluoptics Near Infrared (NIR) imaging technology has helped Halle University Hospital in Germany reduce unintentional removal of parathyroid tissue, which can cause serious consequences for patients undergoing endocrine surgery.

24.06.2025
Getinge's production facility in Halland is now powered by 99.9 percent renewable energy

Getinge has successfully installed solar panels on the roof of its production facility in the Halland town of Getinge. Combined with electricity from a nearby solar park, this means that 99.9% of the energy used at the production facility now comes from renewable sources.

Press Contacts

Alexandra Holland

Alexandra Holland

EVP Brand & Communication
Phone: +1 908 930 8661

Caroline Örmgård, Getinge Head of Public & Media Relations

Caroline Örmgård

Head of Public & Media Relations
Phone: +46 10 335 0041

Newsroom2

Contact us online

Click below to fill in the appropriate form. We will be in touch shortly.

Are you looking for

Getinge Hybrid OR

Image Gallery

Diverse picture format made available for press article purpose 

Man and woman looking a something together

About us

All you need to know about Getinge a one glance

Cardiosave

Urgent Medical Device Correction

Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)

Newsroom

Don't miss anything

Click on the icons and follow us!